These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10212357)

  • 1. The placebo effect in ambulatory blood pressure monitoring.
    Coca A
    Blood Press Monit; 1998 Jun; 3(3):195199. PubMed ID: 10212357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs: methodological aspects.
    Chamontin B
    Blood Press Monit; 1996 Jun; 1(3):213-216. PubMed ID: 10226229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.
    Waeber B; Brunner HR
    Blood Press Monit; 1999 Oct; 4(5):263-6. PubMed ID: 10547648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated measurements of non-invasive ambulatory blood pressure: distinction between reproducibility and the proper effect of placebo.
    Asmar R; Boutelant S; Chaignon M; Guedon J; Topouchian J; Mallion JM; Safar M
    Blood Press Monit; 1996 Jun; 1(3):283-288. PubMed ID: 10226245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambulatory blood pressure monitoring and clinical trials].
    Andréjak M; Mallion JM; Asmar R; Chau NG; de Gaudemaris R; Drici M; Herpin D; Poncelet P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1175-8. PubMed ID: 8572868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.
    Gimpel C; Wühl E; Arbeiter K; Drozdz D; Trivelli A; Charbit M; Gellermann J; Dusek J; Jankauskiene A; Emre S; Schaefer F;
    J Hypertens; 2009 Aug; 27(8):1568-74. PubMed ID: 19550356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine.
    Lacourcière Y; Lenis J; Orchard R; Lewanczuk R; Houde M; Pesant Y; Wright J; Wilson T; Martin K
    Blood Press Monit; 1998 Oct; 3(5):295-302. PubMed ID: 10212369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduct of therapeutic trials.
    Vaïsse B
    Blood Press Monit; 1996 Jun; 1(3):237-240. PubMed ID: 10226235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in response of blood pressure to calcium antagonism in the treatment of moderate-to-severe hypertension.
    Loeb ED; Diamond JA; Krakoff LR; Phillips RA
    Blood Press Monit; 1999 Oct; 4(5):209-12. PubMed ID: 10547639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory monitoring of the blood pressure in multicenter clinical trials.
    White WB; Walsh SJ
    Blood Press Monit; 1996 Jun; 1(3):227-229. PubMed ID: 10226232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aims of ambulatory blood pressure monitoring during phase II and III clinical trials.
    Andréjak MJ
    Blood Press Monit; 1996 Jun; 1(3):309-311. PubMed ID: 10226251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional and ambulatory blood pressure measurement in older patients with isolated systolic hypertension:second progress report on the ambulatory blood pressure monitoring project in the Syst-Eur trial.
    Thijs L; Celis H; Clement D; Gil-Extremera B; Kawecka-Jaszcz K; Mancia G; Parati G; Salvetti A; Sarti C; van den Meiracker AH ; O'Brien E; Staessen JA; Fagard R
    Blood Press Monit; 1996 Apr; 1(2):95-103. PubMed ID: 10226209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it possible to file and approve a new antihypertensive without ambulatory blood pressure monitoring?
    Meyer-Sabellek WA
    Blood Press Monit; 1996 Jun; 1(3):317-319. PubMed ID: 10226253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The trained observer better predicts daytime ABPM diastolic blood pressure in hypertensive patients than does an automated (Omron) device.
    Graves JW; Grossardt BR; Gullerud RE; Bailey KR; Feldstein J
    Blood Press Monit; 2006 Apr; 11(2):53-8. PubMed ID: 16534405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials.
    Coats AJ
    Blood Press Monit; 1996 Apr; 1(2):157-160. PubMed ID: 10226219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.